Deal Library / Pharma BD Deal Intelligence

Royalty Pharma — Pharma Deals

The Pharma Closeout tracks 7 deals, $3.5B in disclosed deal value for Royalty Pharma.

Median Critic Score: 88

All 7 deals

• Royalty Pharma / Zealand Pharma A/S — 2026 · $100M
• Royalty Pharma / Neurimmune AG (NI006 license) — 2026 · $425M
• Royalty Pharma / BeOne Medicines Ltd. — 2025 · $950M
• Royalty Pharma / ImmuNext, Inc. — 2024 · $525M
• Royalty Pharma / Geron — 2024 · $125M
• Royalty Pharma / Ionis — 2023 · $1.1B
• Royalty Pharma / Biohaven Pharmaceutical Holding Co. Ltd. (rimegepant funding) — 2019 · $200M

← Deal Library  ·  Interactive search  ·  How we score deals